SIRT1下调致Akt-p53信号通路失调增加糖尿病心肌缺血易损性及其机制

基本信息
批准号:81600235
项目类别:青年科学基金项目
资助金额:17.50
负责人:丁铭格
学科分类:
依托单位:西安交通大学
批准年份:2016
结题年份:2019
起止时间:2017-01-01 - 2019-12-31
项目状态: 已结题
项目参与者:雷靖祎,季乐乐,付锋,吴冠吉,李涛,邢媛,杨濛
关键词:
沉默调节蛋白1糖尿病乙酰化修饰蛋白激酶B心肌缺血/再灌注损伤
结项摘要

Diabetic hearts are more sensitive to ischemic injury than non-diabetic hearts. However, the mechanisms are unclear. Myocardial ischemia/reperfusion (MI/R) injury has been shown to be associated with the activation of Akt-p53 signaling pathway. Pro-apoptotic p53 is known to be inhibited by Akt that promotes cell survival. We recently found that diabetic I/R hearts showed blocked activation of Akt and enhanced activity of p53, suggesting dysregulated Akt-p53 signaling pathway may participate in increased ischemic vulnerability of diabetic heart. Our further study found that diabetic hearts exhibited reduced deacetylase SIRT1 expression and increased Akt/p53 acetylation, which may be one important mechanism that account for dysregulated Akt-p53 signaling pathway. Based on these previous researches, we aimed to determine whether down-regulated SIRT1 led to increased Akt/p53 acetylation and then disturbed Akt-p53 signaling pathway, which made the diabetic hearts more sensitive to I/R injury. The present study was designed to clarify the role of SIRT1-deacetylated Akt-p53 signaling pathway in the diabetic MI/R injury. This research is hoped to further understand the pathogenesis of increased ischemic vulnerability in diabetic heart and provide novel possible targets for the treatment of ischemic heart disease in diabetic patients.

糖尿病心肌缺血易损性增加,然而其机制尚不清楚。前期研究显示,心肌缺血后Akt-p53信号通路被激活,促生存的Akt可在一定程度上抑制p53的促凋亡效应,而我们新近的预实验发现,糖尿病心肌缺血后Akt激活受阻,p53活性增强,提示Akt-p53信号通路失调与糖尿病心肌缺血易损性增加有关。进一步的研究发现,糖尿病心肌去乙酰化酶SIRT1表达下调,Akt与p53乙酰化水平增加,可能是Akt-p53信号通路失调的重要机制。本课题拟在前期研究基础上,探讨糖尿病心肌SIRT1下调可否增加Akt与p53乙酰化水平,使得心肌缺血后Akt激活受阻,p53活性增强,导致Akt-p53信号通路失调,从而加重缺血损伤。本研究期望阐明SIRT1去乙酰化调节Akt-p53信号通路在糖尿病心肌缺血损伤中的作用,为深入认识糖尿病心肌缺血损伤机理提供实验依据,并为糖尿病性心脏病的防治提供新策略和新思路。

项目摘要

糖尿病心肌对缺血的耐受力降低,缺血易损性增加。包括缺血后处理在内的一些干预措施对糖尿病心肌的保护效果受损。在本项目资助下我们发现:糖尿病心肌缺血再灌注损伤加重,Akt激活受阻,p53活性变化不明显,缺血后处理不能有效激活Akt信号通路;腺病毒转染上调糖尿病心肌SIRT1后,乙酰化Akt表达减少,缺血再灌注损伤减轻,缺血后处理可激活Akt信号通路保护心肌;在SIRT1敲除心肌,乙酰化Akt表达增加,缺血再灌注损伤加重,缺血后处理不能有效激活Akt信号通路保护心肌;高糖环境上调野生型而非突变型SIRT1可恢复缺氧后处理激活Akt信号通路保护心肌细胞的效应,去乙酰化修饰Akt可增加其减轻心肌细胞缺氧损伤的效应,乙酰化修饰Akt可阻断其保护效应。本研究阐明了SIRT1在糖尿病心肌缺血损伤加重和后处理失效中的作用及机制,提示临床上激活SIRT1信号分子对糖尿病相关的心脏疾病进行干预可能具有积极意义。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
2

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

DOI:
发表时间:
3

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

DOI:
发表时间:
4

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021
5

坚果破壳取仁与包装生产线控制系统设计

坚果破壳取仁与包装生产线控制系统设计

DOI:10.19554/j.cnki.1001-3563.2018.21.004
发表时间:2018

丁铭格的其他基金

相似国自然基金

1

线粒体A激酶锚定蛋白121表达下调致糖尿病心肌缺血易损性增加及机制

批准号:81400197
批准年份:2014
负责人:季乐乐
学科分类:H0202
资助金额:23.00
项目类别:青年科学基金项目
2

糖尿病心肌缺血/再灌注易损性增加的新机制:线粒体蛋白磷酸酶2C下调导致的支链氨基酸代谢异常

批准号:81500272
批准年份:2015
负责人:廉坤
学科分类:H0205
资助金额:18.00
项目类别:青年科学基金项目
3

PINK1下调致线粒体自噬障碍加重糖尿病心肌缺血易损性及长期摄食α-亚麻酸对其改善作用

批准号:81500192
批准年份:2015
负责人:杨倩
学科分类:H0202
资助金额:18.00
项目类别:青年科学基金项目
4

Sirtuin蛋白家族在衰老心肌缺血/再灌注损伤易损性增加中的机制研究

批准号:81470410
批准年份:2014
负责人:陈迈
学科分类:H0202
资助金额:73.00
项目类别:面上项目